@inproceedings{KruegerGoldHueppe1993,
  author    = {Kr{\"u}ger, Hans-Peter and Gold, Rainer and H{\"u}ppe, A.},
  title     = {Coergisms between drugs and alcohol - a psychopharmacological review},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-69850},
  year      = {1993},
  abstract  = {No abstract available.},
  subject      = {Rauschgift},
  language  = {en}
}
@incollection{Krueger1993,
  author    = {Kr{\"u}ger, Hans-Peter},
  title     = {Zur Psychobiologie des Sprechens als zeitstrukturiertes Verhalten und ihre verhaltenstherapeutische Aussagekraft},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-41274},
  publisher      = {Universit{\"a}t W{\"u}rzburg},
  year      = {1993},
  abstract  = {No abstract available},
  language  = {de}
}
@article{KruegerSchoech1993,
  author    = {Kr{\"u}ger, Hans-Peter and Sch{\"o}ch, Heinz},
  title     = {Absenkung der Promillegrenze. Ein zweifelhafter Beitrag zur Verkehrssicherheit},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-41911},
  year      = {1993},
  abstract  = {No abstract available},
  language  = {de}
}
@inproceedings{Krueger1993,
  author    = {Kr{\"u}ger, Hans-Peter},
  title     = {Interaction - toward a precise understanding of a scientific term},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-87088},
  year      = {1993},
  abstract  = {No abstract available.},
  subject      = {Interaktion},
  language  = {en}
}
@inproceedings{Krueger1993,
  author    = {Kr{\"u}ger, Hans-Peter},
  title     = {Effects of low alcohol dosages: A review of the literature},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-69843},
  year      = {1993},
  abstract  = {No abstract available.},
  subject      = {Blutalkohol},
  language  = {en}
}
@incollection{Krueger1995,
  author    = {Kr{\"u}ger, Hans-Peter},
  title     = {Gruppenspezifit{\"a}t der Generalpr{\"a}vention - was aus einer Erh{\"o}hung der Promillegrenze zu lernen ist},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-41904},
  publisher      = {Universit{\"a}t W{\"u}rzburg},
  year      = {1995},
  abstract  = {No abstract available},
  language  = {de}
}
@techreport{NeukumWalterSchumacheretal.2006,
  author    = {Neukum, Alexandra and Walter, Martina and Schumacher, Markus and Kr{\"u}ger, Hans-Peter},
  title     = {Trainingskonzeption und Evaluation des Moduls A: "Gefahrenkognition" (Projekt: Simulation von Einsatzfahrten im Auftrag des Pr{\"a}sidiums der Bayerischen Bereitschaftspolizei, Abschlussbericht - Teil I)},
  organization    = {Interdisziplin{\"a}res Zentrum f{\"u}r Verkehrswissenschaften an der Universit{\"a}t W{\"u}rzburg},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-77833},
  year      = {2006},
  abstract  = {Mit dem Ziel der Optimierung der bestehenden polizeilichen Fahrausbildung hat das Pr{\"a}sidium der Bayerischen Bereitschaftspolizei im Jahr 2001 ein mehrj{\"a}hriges Pilotprojekt initiiert, in dem ein technologiegest{\"u}tztes und didaktisch begr{\"u}ndetes Ausbildungssystem entwickelt und erprobt werden sollte. Im Zentrum dieses Pilotprojekts stand die Frage der Anwendung moderner Simulationstechnologie in der Fahrausbildung. Inhaltliche Entwicklung und Projektevaluation oblagen dem IZVW. Das Pilotprojekt ist integriert in das Gesamtcurriculum der Fahrausbildung bei der Bayerischen Bereitschaftspolizei (Rager \& M{\"u}ller, 2000). Dieses basiert auf drei unterschiedlichen Ausbildungsbl{\"o}cken und umfasst insgesamt 93 Unterrichtseinheiten. Die Inhalte des dreistufigen Programms im Rahmen der Ausbildung f{\"u}r den mittleren Polizeivollzugsdienst sind gekennzeichnet als „Situations- und typenbezogenes Fahrtraining" (Stufe 1), „Sicherheitstraining mit Gefahrenlehre" (Stufe II) und „Gefahrentraining zur Bew{\"a}ltigung von Einsatzfahrten mit und ohne Inanspruchnahme von Sonder- und Wegerechten" (Stufe III). In dieser letzten Ausbildungsstufe ist das Pilotprojekt „Simulation von Einsatzfahrten" positioniert. Das verkehrswissenschaftliche Projekt setzte sich zum Ziel, in enger Zusammenarbeit mit polizeilichen Experten und Ausbildern eine an den Erfordernissen der beruflichen Praxis orientierte Ausbildungs- und Trainingskonzeption zu entwickeln und insbesondere die Anwendung der Simulationsmethodik innerhalb der Fahrausbildung zu evaluieren. Der vorliegende Text konzentriert sich als Teil der Abschlussdokumentation auf die Evaluation des Simulatortrainings. Dieses ist konzipiert als zentraler Bestandteil des inhaltlichen Moduls „Gefahrenkognition" und wird erg{\"a}nzt durch ein vorbereitendes computerbasiertes Training. Gegenstand dieses Berichts sind die Arbeiten zur Erfassung von Trainingsakzeptanz und Lernerfolg der Lerneinheit Gefahrenkognition. Hierzu wird zun{\"a}chst ein {\"U}berblick {\"u}ber aktuelle in der Literatur vorliegende Studien gegeben, die sich mit der Evaluation der Simulation als Lehrmethode in der Fahrausbildung besch{\"a}ftigen. Kapitel 3 gibt einen {\"U}berblick {\"u}ber die Inhalte des Moduls und den Aufbau der {\"U}bungen in CBT und Simulator. Fragestellungen, Konzeption und methodisches Vorgehen der Evaluationsuntersuchungen sind beschrieben in Kapitel 4. Die Darstellung der Ergebnisse erfolgt in den Abschnitten 5 bis 7.},
  subject      = {Verkehrssicherheit},
  language  = {de}
}
@article{ElHelouBiegnerBodeetal.2019,
  author    = {El-Helou, Sabine M. and Biegner, Anika-Kerstin and Bode, Sebastian and Ehl, Stephan R. and Heeg, Maximilian and Maccari, Maria E. and Ritterbusch, Henrike and Speckmann, Carsten and Rusch, Stephan and Scheible, Raphael and Warnatz, Klaus and Atschekzei, Faranaz and Beider, Renata and Ernst, Diana and Gerschmann, Stev and Jablonka, Alexandra and Mielke, Gudrun and Schmidt, Reinhold E. and Sch{\"u}rmann, Gesine and Sogkas, Georgios and Baumann, Ulrich H. and Klemann, Christian and Viemann, Dorothee and Bernuth, Horst von and Kr{\"u}ger, Renate and Hanitsch, Leif G. and Scheibenbogen, Carmen M. and Wittke, Kirsten and Albert, Michael H. and Eichinger, Anna and Hauck, Fabian and Klein, Christoph and Rack-Hoch, Anita and Sollinger, Franz M. and Avila, Anne and Borte, Michael and Borte, Stephan and Fasshauer, Maria and Hauenherm, Anja and Kellner, Nils and M{\"u}ller, Anna H. and {\"U}lzen, Anett and Bader, Peter and Bakhtiar, Shahrzad and Lee, Jae-Yun and Heß, Ursula and Schubert, Ralf and W{\"o}lke, Sandra and Zielen, Stefan and Ghosh, Sujal and Laws, Hans-Juergen and Neubert, Jennifer and Oommen, Prasad T. and H{\"o}nig, Manfred and Schulz, Ansgar and Steinmann, Sandra and Klaus, Schwarz and D{\"u}ckers, Gregor and Lamers, Beate and Langemeyer, Vanessa and Niehues, Tim and Shai, Sonu and Graf, Dagmar and M{\"u}glich, Carmen and Schmalzing, Marc T. and Schwaneck, Eva C. and Tony, Hans-Peter and Dirks, Johannes and Haase, Gabriele and Liese, Johannes G. and Morbach, Henner and Foell, Dirk and Hellige, Antje and Wittkowski, Helmut and Masjosthusmann, Katja and Mohr, Michael and Geberzahn, Linda and Hedrich, Christian M. and M{\"u}ller, Christiane and R{\"o}sen-Wolff, Angela and Roesler, Joachim and Zimmermann, Antje and Behrends, Uta and Rieber, Nikolaus and Schauer, Uwe and Handgretinger, Rupert and Holzer, Ursula and Henes, J{\"o}rg and Kanz, Lothar and Boesecke, Christoph and Rockstroh, J{\"u}rgen K. and Schwarze-Zander, Carolynne and Wasmuth, Jan-Christian and Dilloo, Dagmar and H{\"u}lsmann, Brigitte and Sch{\"o}nberger, Stefan and Schreiber, Stefan and Zeuner, Rainald and Ankermann, Tobias and Bismarck, Philipp von and Huppertz, Hans-Iko and Kaiser-Labusch, Petra and Greil, Johann and Jakoby, Donate and Kulozik, Andreas E. and Metzler, Markus and Naumann-Bartsch, Nora and Sobik, Bettina and Graf, Norbert and Heine, Sabine and Kobbe, Robin and Lehmberg, Kai and M{\"u}ller, Ingo and Herrmann, Friedrich and Horneff, Gerd and Klein, Ariane and Peitz, Joachim and Schmidt, Nadine and Bielack, Stefan and Groß-Wieltsch, Ute and Classen, Carl F. and Klasen, Jessica and Deutz, Peter and Kamitz, Dirk and Lassy, Lisa and Tenbrock, Klaus and Wagner, Norbert and Bernbeck, Benedikt and Brummel, Bastian and Lara-Villacanas, Eusebia and M{\"u}nstermann, Esther and Schneider, Dominik T. and Tietsch, Nadine and Westkemper, Marco and Weiß, Michael and Kramm, Christof and K{\"u}hnle, Ingrid and Kullmann, Silke and Girschick, Hermann and Specker, Christof and Vinnemeier-Laubenthal, Elisabeth and Haenicke, Henriette and Schulz, Claudia and Schweigerer, Lothar and M{\"u}ller, Thomas G. and Stiefel, Martina and Belohradsky, Bernd H. and Soetedjo, Veronika and Kindle, Gerhard and Grimbacher, Bodo},
  title     = {The German national registry of primary immunodeficiencies (2012-2017)},
  series = {Frontiers in Immunology},
  volume    = {10},
  journal   = {Frontiers in Immunology},
  doi       = {10.3389/fimmu.2019.01272},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-226629},
  year      = {2019},
  abstract  = {Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs. Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel. Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1-25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57\% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36\% of patients. Familial cases were observed in 21\% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0-88 years). Presenting symptoms comprised infections (74\%) and immune dysregulation (22\%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE-syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49\% of all patients received immunoglobulin G (IgG) substitution (70\%-subcutaneous; 29\%-intravenous; 1\%-unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy. Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.},
  language  = {en}
}
@article{StephanTascilarYalcinMutluetal.2023,
  author    = {Stephan, Marlene and Tascilar, Koray and Yalcin-Mutlu, Melek and Hagen, Melanie and Haschka, Judith and Reiser, Michaela and Hartmann, Fabian and Kleyer, Arnd and Hueber, Axel J. and Manger, Bernhard and Figueiredo, Camille and Cobra, Jayme Fogagnolo and Tony, Hans-Peter and Finzel, Stephanie and Kleinert, Stefan and Wendler, J{\"o}rg and Schuch, Florian and Ronneberger, Monika and Feuchtenberger, Martin and Fleck, Martin and Manger, Karin and Ochs, Wolfgang and Schmitt-Haendle, Matthias and Lorenz, Hannes Martin and N{\"u}sslein, Hubert and Alten, Rieke and Henes, Joerg and Kr{\"u}ger, Klaus and Schett, Georg and Rech, J{\"u}rgen},
  title     = {Physical function of RA patients tapering treatment — a post hoc analysis of the randomized controlled RETRO trial},
  series = {Journal of Clinical Medicine},
  volume    = {12},
  journal   = {Journal of Clinical Medicine},
  number    = {11},
  issn      = {2077-0383},
  doi       = {10.3390/jcm12113723},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-319349},
  year      = {2023},
  abstract  = {Several studies have shown that tapering or stopping disease-modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) patients in sustained remission is feasible. However, tapering/stopping bears the risk of decline in physical function as some patients may relapse and face increased disease activity. Here, we analyzed the impact of tapering or stopping DMARD treatment on the physical function of RA patients. The study was a post hoc analysis of physical functional worsening for 282 patients with RA in sustained remission tapering and stopping DMARD treatment in the prospective randomized RETRO study. HAQ and DAS-28 scores were determined in baseline samples of patients continuing DMARD (arm 1), tapering their dose by 50\% (arm 2), or stopping after tapering (arm 3). Patients were followed over 1 year, and HAQ and DAS-28 scores were evaluated every 3 months. The effect of treatment reduction strategy on functional worsening was assessed in a recurrent-event Cox regression model with a study-group (control, taper, and taper/stop) as the predictor. Two-hundred and eighty-two patients were analyzed. In 58 patients, functional worsening was observed. The incidences suggest a higher probability of functional worsening in patients tapering and/or stopping DMARDs, which is likely due to higher relapse rates in these individuals. At the end of the study, however, functional worsening was similar among the groups. Point estimates and survival curves show that the decline in functionality according to HAQ after tapering or discontinuation of DMARDs in RA patients with stable remission is associated with recurrence, but not with an overall functional decline.},
  language  = {en}
}